NYSE$PRA
ProAssurance Corporation · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
ProAssurance reported Q3 2025 total revenues of $279.6M with net income of $1.4M and diluted EPS of $0.03.
Third-quarter total revenues were $279.6 million with net income of $1.4 million and diluted EPS of $0.03. Specialty property and casualty underwriting, workers' compensation, and segregated portfolio cell reinsurance results were discussed alongside investment gains and merger-related costs with The Doctors Company.
- Q3 total revenues $279.6M.
- Net income $1.4M; diluted EPS $0.03.
- Net losses and LAE $186.2M in the quarter.
- Pending merger with The Doctors Company cited in MD&A.
Headline financials
Revenue & EPS history
ProAssurance · Revenue · Quarterly
$280M
Revenue by segment
ProAssurance · $272M total across 4 segments · Q4 2024
- Specialty P&C$187M—68.7%
- Workers' Compensation Insurance$43.3M—15.9%
- Corporate$29.5M—10.9%
- Segregated Portfolio Cell Reinsurance$12.4M—4.5%
Forward guidance
ProAssurance is pursuing a merger with The Doctors Company while managing specialty medical liability reserves and workers' compensation trends. The insurer discusses pricing, investment income, and capital management in its quarterly filing without issuing explicit EPS guidance.
Tailwinds
- Investment gains contributed $2.1M in Q3.
- Specialty P&C premium trends stable year over year.
- Book value supported by reserve adequacy reviews.
- Dividend maintained for shareholders.
Headwinds
- Merger transaction costs of ~$3.0M in Q3.
- Low GAAP net income relative to premium volume.
- Medical malpractice loss severity uncertainty.
- Interest expense on debt facilities.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
-0.4%
Avg return
Earnings day
-1.1%
Avg return
5 days after
-0.7%
Avg return
30 days after
56%
38 / 68 earnings
Positive
+18.1%
Q2 2024
Best reaction
-22.1%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.0% | +0.2% | -0.5% | |
| Q4 2025 | +0.4% | +0.6% | +1.3% | |
| Q3 2025 | +0.2% | +0.3% | -0.4% | |
| Q1 2025 | -0.2% | +0.2% | +0.8% | |
| Q4 2024 | +14.3% | +10.8% | +65.5% | |
| Q3 2024 | +3.0% | +3.7% | +2.5% | |
| Q2 2024 | +18.1% | +15.5% | +14.6% | |
| Q1 2024 | +9.6% | +6.9% | +0.7% | |
| Q4 2023 | -4.7% | +0.2% | -0.8% | |
| Q3 2023 | -22.1% | -27.6% | -27.7% | |
| Q2 2023 | +8.2% | +8.2% | +3.7% | |
| Q1 2023 | -21.5% | -21.3% | -22.5% | |
| Q4 2022 | +4.7% | +3.7% | -5.9% | |
| Q3 2022 | -12.7% | -11.2% | -14.4% | |
| Q2 2022 | +6.1% | +6.7% | -4.3% | |
| Q1 2022 | -12.7% | -15.0% | -8.0% | |
| Q4 2021 | +1.1% | -0.9% | +3.4% | |
| Q3 2021 | -0.9% | -2.0% | -6.3% | |
| Q2 2021 | +5.4% | +17.5% | +23.7% | |
| Q1 2021 | +1.1% | -3.1% | -6.8% | |
| Q4 2020 | +5.0% | +5.6% | +13.7% | |
| Q3 2020 | -10.2% | +2.0% | +8.6% | |
| Q2 2020 | -2.1% | -5.1% | -12.2% | |
| Q1 2020 | -18.0% | -22.1% | -17.0% | |
| Q4 2019 | -0.2% | -5.4% | -22.7% | |
| Q3 2019 | +1.4% | -1.6% | -5.3% | |
| Q2 2019 | -0.6% | +1.6% | +3.7% | |
| Q1 2019 | -0.9% | +4.2% | +6.7% | |
| Q4 2018 | -3.7% | -9.3% | -22.3% | |
| Q3 2018 | +4.2% | -0.4% | -4.9% | |
| Q2 2018 | +5.5% | +6.8% | +16.1% | |
| Q1 2018 | -13.5% | -12.7% | -17.2% | |
| Q4 2017 | -6.9% | -5.4% | -7.5% | |
| Q3 2017 | +6.1% | +5.5% | +7.7% | |
| Q2 2017 | -5.0% | -6.0% | -10.7% | |
| Q1 2017 | +1.1% | -2.4% | -1.0% | |
| Q4 2016 | +8.9% | +4.9% | +4.0% | |
| Q3 2016 | -2.5% | -1.6% | +10.6% | |
| Q2 2016 | +2.4% | +5.4% | +5.7% | |
| Q1 2016 | +1.1% | — | — | |
| Q4 2015 | -3.3% | — | — | |
| Q3 2015 | -0.9% | — | — | |
| Q2 2015 | +0.1% | — | — | |
| Q1 2015 | -3.5% | — | — | |
| Q4 2014 | +0.1% | — | — | |
| Q3 2014 | -4.9% | — | — | |
| Q2 2014 | -0.4% | — | — | |
| Q1 2014 | -0.6% | — | — | |
| Q4 2013 | -2.2% | — | — | |
| Q3 2013 | +2.7% | — | — | |
| Q2 2013 | -6.3% | — | — | |
| Q1 2013 | +0.1% | — | — | |
| Q4 2012 | +0.9% | — | — | |
| Q3 2012 | -1.9% | — | — | |
| Q2 2012 | +0.9% | — | — | |
| Q1 2012 | +1.5% | — | — | |
| Q4 2011 | +5.7% | — | — | |
| Q4 2010 | +5.7% | — | — | |
| Q3 2011 | +2.0% | — | — | |
| Q2 2011 | +1.8% | — | — | |
| Q1 2010 | +0.4% | — | — | |
| Q1 2011 | +0.6% | — | — | |
| Q4 2008 | +8.2% | — | — | |
| Q3 2009 | +4.2% | — | — | |
| Q3 2010 | +4.2% | — | — | |
| Q2 2010 | -3.5% | — | — | |
| Q2 2009 | -3.5% | — | — | |
| Q4 2009 | -3.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro